WO2002047718A3 - Methods and compositions for vaccination comprising nucleic acid ad/or polypeptide sequences of $i(chlamydia) - Google Patents
Methods and compositions for vaccination comprising nucleic acid ad/or polypeptide sequences of $i(chlamydia) Download PDFInfo
- Publication number
- WO2002047718A3 WO2002047718A3 PCT/US2001/048773 US0148773W WO0247718A3 WO 2002047718 A3 WO2002047718 A3 WO 2002047718A3 US 0148773 W US0148773 W US 0148773W WO 0247718 A3 WO0247718 A3 WO 0247718A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- vaccination
- antigens
- chlamydia
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002241642A AU2002241642A1 (en) | 2000-12-15 | 2001-12-17 | Methods and compositions for vaccination comprising nucleic acid ad/or polypeptide sequences of $i(chlamydia) |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25583900P | 2000-12-15 | 2000-12-15 | |
US60/255,839 | 2000-12-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002047718A2 WO2002047718A2 (en) | 2002-06-20 |
WO2002047718A3 true WO2002047718A3 (en) | 2003-08-14 |
Family
ID=22970078
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/048773 WO2002047718A2 (en) | 2000-12-15 | 2001-12-17 | Methods and compositions for vaccination comprising nucleic acid ad/or polypeptide sequences of $i(chlamydia) |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002241642A1 (en) |
WO (1) | WO2002047718A2 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5212062A (en) * | 1991-09-06 | 1993-05-18 | Kansas State University | Method and composition to direct Chlamydia psittaci or Chlamydia trachomatis infection |
WO1999053948A1 (en) * | 1998-04-20 | 1999-10-28 | THE STATE OF OREGON, acting by and through THE STATE BOARD OF HIGHER EDUCATION, on behalf of OREGON STATE UNIVERSITY | Chlamydia proteins and their uses |
US5989553A (en) * | 1995-04-07 | 1999-11-23 | Board Of Regents, The University Of Texas System | Expression library immunization |
WO2002053588A2 (en) * | 2000-12-15 | 2002-07-11 | Board Of Regents, The University Of Texas System | Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of chlamydia psittaci |
-
2001
- 2001-12-17 AU AU2002241642A patent/AU2002241642A1/en not_active Abandoned
- 2001-12-17 WO PCT/US2001/048773 patent/WO2002047718A2/en not_active Application Discontinuation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5212062A (en) * | 1991-09-06 | 1993-05-18 | Kansas State University | Method and composition to direct Chlamydia psittaci or Chlamydia trachomatis infection |
US5989553A (en) * | 1995-04-07 | 1999-11-23 | Board Of Regents, The University Of Texas System | Expression library immunization |
WO1999053948A1 (en) * | 1998-04-20 | 1999-10-28 | THE STATE OF OREGON, acting by and through THE STATE BOARD OF HIGHER EDUCATION, on behalf of OREGON STATE UNIVERSITY | Chlamydia proteins and their uses |
WO2002053588A2 (en) * | 2000-12-15 | 2002-07-11 | Board Of Regents, The University Of Texas System | Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of chlamydia psittaci |
Non-Patent Citations (2)
Title |
---|
KALTENBOECK B ET AL: "FULLY PROTECTIVE VACCINE CANDIDATE GENES OF CHLAMYDIA PSITTACI IDENTIFIED BY RANDOM EXPRESSION LIBRARY IMMUNIZATION", FASEB JOURNAL, FED. OF AMERICAN SOC. FOR EXPERIMENTAL BIOLOGY, BETHESDA, MD, US, vol. 14, no. 6, 20 April 2000 (2000-04-20), pages A1130, XP001109590, ISSN: 0892-6638 * |
KALTENBOECK ET AL: "Use of synthetic antigens improves detection by enzyme-linked immunoabsorbent assay of antibodies against abortigenic Chlamydia psittaci in ruminants", JOURNAL OF CLINICAL MICROBIOLOGY, WASHINGTON, DC, US, vol. 35, no. 9, September 1997 (1997-09-01), pages 2293 - 2298, XP002160438, ISSN: 0095-1137 * |
Also Published As
Publication number | Publication date |
---|---|
AU2002241642A1 (en) | 2002-06-24 |
WO2002047718A2 (en) | 2002-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004026265A3 (en) | Compositions and methods for treatment of herpesvirus infections | |
WO1999040188A3 (en) | Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccinations | |
WO2004103269A3 (en) | Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of the genus borrelia | |
WO2003049762A3 (en) | Immunisation against chlamydia trachomatis | |
TW200732346A (en) | Chimeric hepatitis C virus antigens for eliciting an immune response | |
AU2003244855A1 (en) | Method to enhance an immune response of nucleic acid vaccination | |
EP2330129A3 (en) | Anti-TNF antibodies, compositions, methods and uses | |
WO2003059381A3 (en) | Immunogenic preparations and vaccines on the basis of mrna | |
NZ540544A (en) | Nucleic acids and proteins from streptococcus groups A & B | |
WO2001083559A3 (en) | Production and use of protein variants having modified immunogenecity | |
WO2001096368A3 (en) | Use of coiled-coil structural scaffold to generate structure-specific peptides | |
WO2001085932A3 (en) | Immunogenic polypeptides encoded by mage minigenes and uses thereof | |
WO2000056901A3 (en) | Linear and circular expression elements | |
WO2002053588A3 (en) | Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of chlamydia psittaci | |
WO2000006736A3 (en) | Nucleic acids and proteins from group b streptococcus | |
WO2004098526A3 (en) | Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein | |
WO2001032882A3 (en) | Nucleic acids and proteins from group b streptococcus | |
WO2002020038A3 (en) | Method for down-regulating ige | |
WO2005035779A3 (en) | Method | |
AU5554301A (en) | Isolation and characterization of the csa operon (etec-cs4 pili) and methods of using same | |
WO2000063385A3 (en) | Nucleic acid immunization | |
WO2002063010A3 (en) | Method of producing recombinant antibodies against tumors | |
WO2002028998A3 (en) | Chlamydia pmp proteins, gene sequences and uses thereof | |
WO2002047718A3 (en) | Methods and compositions for vaccination comprising nucleic acid ad/or polypeptide sequences of $i(chlamydia) | |
WO2002094313A3 (en) | Vaccine composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |